viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Lisinopril
keemiline struktuur
Viited : Lisinopril
tüüp
avaldamine
2389
ajaleht
Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL.
Characterization of an extemporaneous liquid formulation of lisinopril
Am J Health-Syst Pharm 2003 ; 60: 69-74.
2549
ajaleht
Nahata MC, Morosco RS.
Stability of Lisinopril in Two Liquid Dosage Forms
Ann Pharmacotherapy 2004 ;38:396-399.
2665
ajaleht
Webster AA, English BA, Rose DJ.
The stability of lisinopril as an extemporaneous syrup.
Int J Pharm Compound 1997 ; 1: 352-353.
2680
ajaleht
Rose DJ, Webster AA, English BA.
Stability of lisinopril syrup (2 mg/ml) extemporaneously compounded from tablets.
Int J Pharm Compound 2000 : 398-399.
3902
ajaleht
Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O.
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
Int J Pharm Compound 2016 ; 20, 5 : 426-434.
Mentions Légales